Nason Medical Center, Llc | |
105 Nason Drive, Roaring Spring, Pennsylvania 16673 | |
(814) 224-2141 | |
Name | Nason Medical Center, Llc |
---|---|
Type | Acute Care Hospital |
Location | 105 Nason Drive, Roaring Spring, Pennsylvania |
Ownership | Voluntary non-profit - Private |
Emergency Services | Yes |
Medicare ID (CCN) | 390062 |
NPI Number | 1497708473 |
Organization Name | NASON MEDICAL CENTER LLC |
Doing Business As | NASON HOSPITAL |
Address | 105 Nason Dr, Roaring Spring, PA 16673 |
Hospital Type | General Acute Care Hospital |
Phone Number | 814-224-2141 |
News Archive
Thai public health officials plan to continue discussions with international pharmaceutical companies following recent debates over compulsory licenses issued by the country for some medications, U.S. Chamber of Commerce Senior Vice President Daniel Christman said on Tuesday, Reuters UK reports
Children in the child welfare system, especially younger children and those remaining in their homes, have low rates of mental health services use, according to an article in the December issue of The Archives of General Psychiatry, one of the JAMA/Archives journals.
The British Government's strategy on alcohol will do nothing to tackle problem drinking in Britain, because it "embraces the industry's diagnosis and preferred remedies", says an editorial in this week's British Medical Journal (BMJ).
Eli Lilly and Company and Locemia Solutions today announced Lilly has acquired worldwide rights to Locemia's intranasal glucagon, a potential treatment for severe hypoglycemia in people with diabetes treated with insulin. Intranasal glucagon, which is currently in Phase III clinical trial testing, could be the first needle-free rescue treatment for severe hypoglycemia.
Genzyme Corporation announced today that scientists have again named the company a top employer in a survey ranking the reputations of biotechnology and pharmaceutical companies. Genzyme is ranked third on the global list of 575 companies, the second consecutive year it has achieved this position. Genzyme placed among the top 10 of all biotechnology and pharmaceutical companies in the world for the seventh year in a row.
› Verified 2 days ago
Able to receive lab results electronically | Yes |
Able to track patients' lab results, tests, and referrals electronically between visits | Yes |
News Archive
Thai public health officials plan to continue discussions with international pharmaceutical companies following recent debates over compulsory licenses issued by the country for some medications, U.S. Chamber of Commerce Senior Vice President Daniel Christman said on Tuesday, Reuters UK reports
Children in the child welfare system, especially younger children and those remaining in their homes, have low rates of mental health services use, according to an article in the December issue of The Archives of General Psychiatry, one of the JAMA/Archives journals.
The British Government's strategy on alcohol will do nothing to tackle problem drinking in Britain, because it "embraces the industry's diagnosis and preferred remedies", says an editorial in this week's British Medical Journal (BMJ).
Eli Lilly and Company and Locemia Solutions today announced Lilly has acquired worldwide rights to Locemia's intranasal glucagon, a potential treatment for severe hypoglycemia in people with diabetes treated with insulin. Intranasal glucagon, which is currently in Phase III clinical trial testing, could be the first needle-free rescue treatment for severe hypoglycemia.
Genzyme Corporation announced today that scientists have again named the company a top employer in a survey ranking the reputations of biotechnology and pharmaceutical companies. Genzyme is ranked third on the global list of 575 companies, the second consecutive year it has achieved this position. Genzyme placed among the top 10 of all biotechnology and pharmaceutical companies in the world for the seventh year in a row.
› Verified 2 days ago
Nason Medical Center, Llc Acute Care Hospital Location: 105 Nason Drive, Roaring Spring, Pennsylvania 16673 Phone: (814) 224-2141 |